Browsing: GSK

David Dee DelgadoPfizer (NYSE:PFE) has made significant updates to its diversity, equity, and inclusion (DEI) webpage, becoming the latest Big…

Wirestock/iStock Editorial via Getty Images GSK (NYSE:GSK) said that it will no longer set “aspirational targets” — a reference to…

Magdalena WygralakGSK (NYSE:GSK) announced Tuesday that the EU drug regulator has agreed to review depemokimab, an experimental monoclonal antibody targeting…

Wirestock/iStock Editorial via Getty Images GSK (NYSE:GSK) finalized the deal to acquire Boston-based, clinical-stage biopharmaceutical company—IDRx for a total of…